CY1108832T1 - Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα - Google Patents
Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμαInfo
- Publication number
- CY1108832T1 CY1108832T1 CY20091100230T CY091100230T CY1108832T1 CY 1108832 T1 CY1108832 T1 CY 1108832T1 CY 20091100230 T CY20091100230 T CY 20091100230T CY 091100230 T CY091100230 T CY 091100230T CY 1108832 T1 CY1108832 T1 CY 1108832T1
- Authority
- CY
- Cyprus
- Prior art keywords
- active substance
- patch
- pharmaceutical
- skin
- features above
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 2
- 239000010985 leather Substances 0.000 title 1
- 230000003287 optical effect Effects 0.000 title 1
- 239000011159 matrix material Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Spectrometry And Color Measurement (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Abstract
Φαρμακευτικό έμπλαστρο δραστικής ουσίας το οποίο περιλαμβάνει μονο- ή πολυστιβαδικώς δομημένη μήτρα με τουλάχιστον μία στιβάδα που περιέχει δραστική ουσία καθώς και οπίσθια στιβάδα ενωμένη με αυτή τη μήτρα, χαρακτηριζόμενο από το ότι αυτό είναι διαφανές ή τουλάχιστον ημιδιαφανές και ότι αυτό -στην κατάσταση της εφαρμογής πάνω στο δέρμα ενός πρώτου ατόμου- εμφανίζει σε κάποια θέση δέρματος καλυμμένη με το έμπλαστρο χρωματική τιμή φωτεινότητας L1, η οποία είναι όχι μικρότερη από 50% και όχι μεγαλύτερη από 200% μίας χρωματικής τιμής φωτεινότητας L2, όπου η L2 είναι η τιμή φωτεινότητας επί της δερματικής περιοχής γύρω από το εφαρμοσμένο έμπλαστρο στο ίδιο άτομο, και ότι το ίδιο ισχύει σε σχέση με το δέρμα ενός δεύτερου ή κάθε άλλου ατόμου, εφόσον L2 για όλα τα εν λόγω άτομα είναι στο εύρος 5° και 100°, ιδίως στην περιοχή 20° και 90°.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10317692A DE10317692A1 (de) | 2003-04-17 | 2003-04-17 | Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut |
| EP04726478A EP1615628B1 (de) | 2003-04-17 | 2004-04-08 | Medizinische wirkstoffpflaster mit verringerter optischer auffälligkeit auf der haut |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1108832T1 true CY1108832T1 (el) | 2014-07-02 |
Family
ID=33154271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100230T CY1108832T1 (el) | 2003-04-17 | 2009-02-27 | Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US10653636B2 (el) |
| EP (1) | EP1615628B1 (el) |
| JP (2) | JP5733875B2 (el) |
| KR (1) | KR101052127B1 (el) |
| CN (1) | CN100450472C (el) |
| AT (1) | ATE415954T1 (el) |
| AU (1) | AU2004229159B2 (el) |
| BR (1) | BRPI0409889B8 (el) |
| CA (1) | CA2522962C (el) |
| CY (1) | CY1108832T1 (el) |
| DE (2) | DE10317692A1 (el) |
| DK (1) | DK1615628T3 (el) |
| ES (1) | ES2320550T3 (el) |
| HK (1) | HK1079455A1 (el) |
| IL (1) | IL171399A (el) |
| MX (1) | MXPA05010935A (el) |
| NZ (1) | NZ543195A (el) |
| PL (1) | PL1615628T3 (el) |
| PT (1) | PT1615628E (el) |
| RU (1) | RU2336866C2 (el) |
| SI (1) | SI1615628T1 (el) |
| WO (1) | WO2004091590A1 (el) |
| ZA (1) | ZA200507034B (el) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10317692A1 (de) * | 2003-04-17 | 2004-11-11 | Lts Lohmann Therapie-Systeme Ag | Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut |
| DE102005010255A1 (de) * | 2005-03-07 | 2006-09-14 | Lts Lohmann Therapie-Systeme Ag | Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung |
| CA2618706C (en) | 2005-08-12 | 2018-01-02 | Rick B. Yeager | System and method for medical monitoring and treatment through cosmetic monitoring and treatment |
| US8942775B2 (en) | 2006-08-14 | 2015-01-27 | Tcms Transparent Beauty Llc | Handheld apparatus and method for the automated application of cosmetics and other substances |
| US8184901B2 (en) | 2007-02-12 | 2012-05-22 | Tcms Transparent Beauty Llc | System and method for applying a reflectance modifying agent to change a person's appearance based on a digital image |
| CA2671006A1 (en) * | 2006-12-01 | 2008-06-05 | Nitto Denko Corporation | Method for suppressing discoloration over time of adhesive preparation containing donepezil |
| CN101573115B (zh) * | 2006-12-01 | 2012-06-06 | 日东电工株式会社 | 抑制含有多奈哌齐的贴剂着色的方法、及降低多奈哌齐类似物的生成量的方法 |
| EP2117721B8 (en) | 2007-02-12 | 2012-08-08 | YEAGER, Rick B. | System and method for applying agent electrostatically to human skin |
| US10092082B2 (en) | 2007-05-29 | 2018-10-09 | Tcms Transparent Beauty Llc | Apparatus and method for the precision application of cosmetics |
| RU2481826C2 (ru) * | 2008-05-30 | 2013-05-20 | Нитто Денко Корпорейшн | Содержащий донепезил адгезивный препарат и упаковка для него |
| WO2009145269A1 (ja) * | 2008-05-30 | 2009-12-03 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 経皮吸収製剤 |
| EP3310327A2 (en) * | 2015-06-22 | 2018-04-25 | Johnson & Johnson Consumer Inc. | Method for providing a benefit to skin |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE7529365U (de) | 1976-01-08 | Beiersdorf Ag, 2000 Hamburg | Wund schnell verband | |
| JPS55111416A (en) * | 1979-02-20 | 1980-08-28 | Taisho Pharmaceut Co Ltd | Paster |
| US4594276A (en) * | 1984-04-09 | 1986-06-10 | Minnesota Mining And Manufacturing Company | Printed, removable body tattoos on a translucent substrate |
| JPH0739566B2 (ja) | 1986-02-21 | 1995-05-01 | 積水化学工業株式会社 | 医療用粘着テープもしくはシートの製造方法 |
| US5004610A (en) * | 1988-06-14 | 1991-04-02 | Alza Corporation | Subsaturated nicotine transdermal therapeutic system |
| US5004510A (en) * | 1989-01-30 | 1991-04-02 | Panzhihua Iron & Steel Co. | Process for manufacturing high strength railroad rails |
| DE4030465C2 (de) * | 1990-09-26 | 1994-06-01 | Ruschke Mona | Pflaster |
| US5120325A (en) * | 1991-06-12 | 1992-06-09 | Fleshtones Products Co., Inc. | Color-matched sterile adhesive bandages containing melanin-like pigment composition |
| CA2075517C (en) * | 1992-04-01 | 1997-03-11 | John Wick | Transdermal patch incorporating a polymer film incorporated with an active agent |
| US5264219A (en) * | 1992-08-07 | 1993-11-23 | Minnesota Mining And Manufacturing Company | Transdermal drug delivery backing |
| JPH07206624A (ja) | 1994-01-20 | 1995-08-08 | Shiseido Co Ltd | 皮膚外用剤 |
| US5536263A (en) * | 1994-03-30 | 1996-07-16 | Lectec Corporation | Non-occulusive adhesive patch for applying medication to the skin |
| DE19519593C1 (de) * | 1995-05-29 | 1996-08-29 | Horstmann Michael | Transdermales Therapeutisches System mit druckfarbenfreier Identifikation und Verfahren zu seiner Herstellung |
| US6025535A (en) * | 1996-10-28 | 2000-02-15 | The Procter & Gamble Company | Topsheet for absorbent articles exhibiting improved masking properties |
| JPH11116470A (ja) * | 1997-08-12 | 1999-04-27 | Takeda Chem Ind Ltd | イデベノン含有経皮投与製剤 |
| EP2158903A3 (en) | 1998-12-18 | 2010-04-14 | ALZA Corporation | Transparent Transdermal Nicotine Delivery Devices |
| DE19912623A1 (de) * | 1999-03-20 | 2000-09-28 | Lohmann Therapie Syst Lts | Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile |
| ES2278603T3 (es) * | 2000-04-12 | 2007-08-16 | THE PROCTER & GAMBLE COMPANY | Dispositivos en forma de lamina formados previamente adecuados para aplicacion topica. |
| DE10053375C1 (de) * | 2000-10-27 | 2002-01-24 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
| US8586079B2 (en) * | 2002-06-21 | 2013-11-19 | Graphic Productions Inc. | Promotional simulation for transdermal patch sampler |
| DE10317692A1 (de) * | 2003-04-17 | 2004-11-11 | Lts Lohmann Therapie-Systeme Ag | Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut |
-
2003
- 2003-04-17 DE DE10317692A patent/DE10317692A1/de not_active Withdrawn
-
2004
- 2004-04-08 CA CA2522962A patent/CA2522962C/en not_active Expired - Lifetime
- 2004-04-08 BR BRPI0409889A patent/BRPI0409889B8/pt active IP Right Grant
- 2004-04-08 RU RU2005129528/15A patent/RU2336866C2/ru active
- 2004-04-08 ES ES04726478T patent/ES2320550T3/es not_active Expired - Lifetime
- 2004-04-08 SI SI200431046T patent/SI1615628T1/sl unknown
- 2004-04-08 NZ NZ543195A patent/NZ543195A/xx not_active IP Right Cessation
- 2004-04-08 KR KR1020057019784A patent/KR101052127B1/ko active IP Right Grant
- 2004-04-08 PL PL04726478T patent/PL1615628T3/pl unknown
- 2004-04-08 DK DK04726478T patent/DK1615628T3/da active
- 2004-04-08 DE DE502004008582T patent/DE502004008582D1/de not_active Expired - Lifetime
- 2004-04-08 EP EP04726478A patent/EP1615628B1/de not_active Expired - Lifetime
- 2004-04-08 US US10/553,708 patent/US10653636B2/en active Active
- 2004-04-08 CN CNB2004800102813A patent/CN100450472C/zh not_active Expired - Lifetime
- 2004-04-08 MX MXPA05010935A patent/MXPA05010935A/es active IP Right Grant
- 2004-04-08 WO PCT/EP2004/003748 patent/WO2004091590A1/de active Application Filing
- 2004-04-08 JP JP2006505058A patent/JP5733875B2/ja not_active Ceased
- 2004-04-08 PT PT04726478T patent/PT1615628E/pt unknown
- 2004-04-08 AU AU2004229159A patent/AU2004229159B2/en not_active Expired
- 2004-04-08 AT AT04726478T patent/ATE415954T1/de active
-
2005
- 2005-09-02 ZA ZA200507034A patent/ZA200507034B/en unknown
- 2005-10-11 IL IL171399A patent/IL171399A/en not_active IP Right Cessation
-
2006
- 2006-02-16 HK HK06102053.4A patent/HK1079455A1/xx not_active IP Right Cessation
-
2009
- 2009-02-27 CY CY20091100230T patent/CY1108832T1/el unknown
-
2011
- 2011-12-26 JP JP2011283480A patent/JP2012092133A/ja active Pending
-
2019
- 2019-02-01 US US16/265,427 patent/US10646453B2/en not_active Expired - Lifetime
-
2020
- 2020-03-11 US US16/815,286 patent/US11426358B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108832T1 (el) | Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα | |
| MX2020009757A (es) | Producto combinado de inhibidor de bcl-2 e inhibidor de mdm2 y uso de este en la prevencion y/o tratamiento de enfermedades. | |
| BR0215564A (pt) | Composições tópicas para a pele e/ou cabelo que contêm uma proteìna hidrolisada | |
| CL2004000674A1 (es) | Sistema terapeutico transdermico que comprende al menos una sustancia activa farmaceutica, al menos un disruptor de la estructura y/o al menos un formador de estructura en una matriz comun. | |
| ECSP105739A (es) | Anticuerpos de neutralización contra gdf-8 | |
| BRPI0517237A (pt) | artigo absorvente descartável apresentando sinais visìveis | |
| PT1155692E (pt) | Utilizacao de paclitaxel estabilizado com albumina para a preparacao de um farmaco para o tratamento de tumores solidos e o farmaco assim obtido | |
| CY1106411T1 (el) | Διαδepμικο θepαπευτικο συστημα με fentanyl | |
| ATE402663T1 (de) | Flächiges implantat | |
| BRPI0410503B8 (pt) | composição tópica e uso da composição | |
| BRPI0519242A2 (pt) | uso derivados de 1-aminociclohexano para o tratamento de esclerose méltipla, instabilidade emocional e paralisia pseudobulbar | |
| AR052165A1 (es) | Tratamiento de hepatitis c en la poblacion asiatica | |
| AR050621A1 (es) | Sistema terapeutico transdermal con una capa adherente procedimiento para el siliconado de una capa de respaldo y empleo de la capa de respaldo | |
| ATE353655T1 (de) | Myo-inositol hexaphosphat zur topischen verwendung | |
| AR043248A1 (es) | Sistema terapeutico transdermico estable a los rayos uv | |
| ATE429908T1 (de) | Hormonhaltiges transdermales therapeutisches system mit einem wirkstoffreservoir auf der basis von vinylacetat-vinylpyrrolidon-copolymer mit verbesserter kohäsion. | |
| CO2021013251A2 (es) | Derivados de insulina sensibles a la glucosa | |
| PT1393596E (pt) | Vidro com um revestimento opaco | |
| ES2177783T3 (es) | Uso de la gabapentina y sus derivados en el tratamiento de mania y desorden bipolar. | |
| ATE447978T1 (de) | Kompresse für die kombinierte applikation von naturheilstoffen und elektromagnetischen strahlungen | |
| BR0109893A (pt) | Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente | |
| AR039137A1 (es) | Unidad coherente de sistemas terapeuticos transdermicos separables | |
| CY1115757T1 (el) | Στερεο διαδερμικο θεραπευτικο συστημα που περιλαμβανει uv-απορροφητη | |
| ATE445393T1 (de) | Tablette mit gefärbtem kern | |
| TR199802578T2 (xx) | Deri �tesine trimegeston uygulamaya y�nelik yeni d�zenekler. |